LENSAR Inc
NASDAQ:LNSR
Intrinsic Value
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. [ Read More ]
The intrinsic value of one LNSR stock under the Base Case scenario is 5.46 USD. Compared to the current market price of 3.18 USD, LENSAR Inc is Undervalued by 42%.
Valuation Backtest
LENSAR Inc
Run backtest to discover the historical profit from buying and selling LNSR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
LENSAR Inc
Current Assets | 46.4m |
Cash & Short-Term Investments | 24.1m |
Receivables | 5.3m |
Other Current Assets | 17.1m |
Non-Current Assets | 23.1m |
Long-Term Investments | 492k |
PP&E | 8.1m |
Intangibles | 11m |
Other Non-Current Assets | 3.5m |
Current Liabilities | 11.6m |
Accounts Payable | 4m |
Accrued Liabilities | 6.3m |
Other Current Liabilities | 1.3m |
Non-Current Liabilities | 10.8m |
Other Non-Current Liabilities | 10.8m |
Earnings Waterfall
LENSAR Inc
Revenue
|
42.2m
USD
|
Cost of Revenue
|
-21.1m
USD
|
Gross Profit
|
21.1m
USD
|
Operating Expenses
|
-33.3m
USD
|
Operating Income
|
-12.2m
USD
|
Other Expenses
|
-2.2m
USD
|
Net Income
|
-14.4m
USD
|
Free Cash Flow Analysis
LENSAR Inc
LNSR Profitability Score
Profitability Due Diligence
LENSAR Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
LENSAR Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
LNSR Solvency Score
Solvency Due Diligence
LENSAR Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
LENSAR Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LNSR Price Targets Summary
LENSAR Inc
According to Wall Street analysts, the average 1-year price target for LNSR is 8.16 USD with a low forecast of 8.08 USD and a high forecast of 8.4 USD.
Ownership
LNSR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
LNSR Price
LENSAR Inc
Average Annual Return | -30.1% |
Standard Deviation of Annual Returns | 22.33% |
Max Drawdown | -84% |
Market Capitalization | 36m USD |
Shares Outstanding | 11 400 000 |
Percentage of Shares Shorted | 0.82% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 110 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company has developed the LENSAR Laser System to provide an alternative laser cataract treatment tool that allows the surgeon to better address astigmatism and improve visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The company is also developing an integrated cataract treatment system, ALLY, which is designed to combine its existing femtosecond laser technology with phacoemulsification system into a single unit and allow surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.
Contact
IPO
Employees
Officers
The intrinsic value of one LNSR stock under the Base Case scenario is 5.46 USD.
Compared to the current market price of 3.18 USD, LENSAR Inc is Undervalued by 42%.